FI111078B - Menetelmä mometasonifuroaattimonohydraatin valmistamiseksi - Google Patents
Menetelmä mometasonifuroaattimonohydraatin valmistamiseksi Download PDFInfo
- Publication number
- FI111078B FI111078B FI931031A FI931031A FI111078B FI 111078 B FI111078 B FI 111078B FI 931031 A FI931031 A FI 931031A FI 931031 A FI931031 A FI 931031A FI 111078 B FI111078 B FI 111078B
- Authority
- FI
- Finland
- Prior art keywords
- mometasone furoate
- water
- monohydrate
- organic solvent
- furoate monohydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58023990A | 1990-09-10 | 1990-09-10 | |
US58023990 | 1990-09-10 | ||
US9106249 | 1991-09-06 | ||
PCT/US1991/006249 WO1992004365A1 (en) | 1990-09-10 | 1991-09-06 | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
FI931031A0 FI931031A0 (fi) | 1993-03-09 |
FI931031A FI931031A (fi) | 1993-03-09 |
FI111078B true FI111078B (fi) | 2003-05-30 |
Family
ID=24320279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI931031A FI111078B (fi) | 1990-09-10 | 1993-03-09 | Menetelmä mometasonifuroaattimonohydraatin valmistamiseksi |
Country Status (35)
Country | Link |
---|---|
US (1) | US6180781B1 (xx) |
EP (1) | EP0548114B1 (xx) |
JP (1) | JPH0725789B2 (xx) |
KR (1) | KR960013445B1 (xx) |
CN (1) | CN1030920C (xx) |
AT (1) | ATE113604T1 (xx) |
AU (1) | AU663471B2 (xx) |
BG (1) | BG60755B2 (xx) |
CA (1) | CA2091360C (xx) |
CZ (1) | CZ281318B6 (xx) |
DE (2) | DE69104991T2 (xx) |
DK (1) | DK0548114T5 (xx) |
EE (1) | EE02962B1 (xx) |
ES (1) | ES2065701T3 (xx) |
FI (1) | FI111078B (xx) |
HK (1) | HK185996A (xx) |
HR (1) | HRP920383B1 (xx) |
HU (1) | HU213401B (xx) |
IE (1) | IE67056B1 (xx) |
IL (1) | IL99437A (xx) |
LU (1) | LU90366I2 (xx) |
MX (2) | MX9203396A (xx) |
MY (1) | MY106644A (xx) |
NL (1) | NL980012I2 (xx) |
NO (1) | NO300548B1 (xx) |
NZ (1) | NZ239711A (xx) |
OA (1) | OA09772A (xx) |
PH (1) | PH30443A (xx) |
PL (1) | PL165803B1 (xx) |
PT (1) | PT98905B (xx) |
SI (1) | SI9111497A (xx) |
TW (2) | TW229208B (xx) |
WO (1) | WO1992004365A1 (xx) |
YU (1) | YU48666B (xx) |
ZA (1) | ZA917148B (xx) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL165803B1 (pl) * | 1990-09-10 | 1995-02-28 | Schering Corp | Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL |
PE44995A1 (es) | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
US5837699A (en) | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
US5886200A (en) * | 1996-07-01 | 1999-03-23 | Schering Corporation | Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones |
US5976573A (en) | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
CN1059476C (zh) * | 1996-08-21 | 2000-12-13 | 邓维鹏 | 金黄色铝合金硒盐电解着色方法 |
US6187765B1 (en) * | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
AU9674398A (en) * | 1997-10-09 | 1999-05-03 | Schering Corporation | Mometasone furoate suspensions for nebulization |
MY133181A (en) * | 1998-09-10 | 2007-10-31 | Schering Corp | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
GB0207906D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and mometasone aerosol formulations |
US7811606B2 (en) | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
US9808471B2 (en) | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
AU2004268847A1 (en) * | 2003-08-29 | 2005-03-10 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-IV |
US20070259874A1 (en) * | 2003-11-26 | 2007-11-08 | Palle Venkata P | Phosphodiesterase Inhibitors |
US7491725B2 (en) | 2004-02-06 | 2009-02-17 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
US7915286B2 (en) | 2005-09-16 | 2011-03-29 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
JP2009512677A (ja) * | 2005-10-19 | 2009-03-26 | ランバクシー ラボラトリーズ リミテッド | ホスホジエステラーゼタイプiv阻害剤の組成物 |
US20090221664A1 (en) | 2005-10-19 | 2009-09-03 | Abhijit Ray | Pharmaceutical compositions of muscarinic receptor antagonists |
CN100436473C (zh) * | 2005-12-09 | 2008-11-26 | 天津药业集团有限公司 | 糠酸莫美他松中间体21-酯及制法 |
CN100389121C (zh) * | 2005-12-09 | 2008-05-21 | 天津药业集团有限公司 | 糠酸莫美他松中间体21-羟的制备方法 |
DE102006034883A1 (de) * | 2006-07-25 | 2008-01-31 | Hermal Kurt Herrmann Gmbh & Co. Ohg | Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat |
US20100029728A1 (en) * | 2006-09-22 | 2010-02-04 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
CA2664247A1 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-iv |
EP1958947A1 (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
AP2453A (en) | 2007-03-14 | 2012-08-31 | Ranbaxy Lab Ltd | Pyrazolo(3,4-B) pyridine derivatives as phosphodiesterase inhibitors |
US20110130403A1 (en) * | 2007-03-14 | 2011-06-02 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
US8815258B2 (en) * | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
LT2435025T (lt) | 2009-05-29 | 2016-09-26 | Pearl Therapeutics, Inc. | Veikliosios medžiagos tiekimas per kvėpavimo takus |
PT105058B (pt) | 2010-04-21 | 2013-04-17 | Hovione Farmaciencia S A | Processo para processamento de partículas de ingredientes activos farmacêuticos |
KR102391332B1 (ko) | 2013-03-15 | 2022-04-26 | 펄 테라퓨틱스 인코포레이티드 | 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템 |
CN107266518B (zh) * | 2016-04-08 | 2021-03-30 | 天津金耀集团有限公司 | 一种糠酸莫米松晶型及其制备方法 |
CN107260671B (zh) * | 2016-04-08 | 2021-03-26 | 天津金耀集团有限公司 | 一种糠酸莫米松混悬鼻喷剂组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3260474D1 (en) * | 1981-02-02 | 1984-09-06 | Schering Corp | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them |
US4783444A (en) | 1984-09-17 | 1988-11-08 | Schering Corporation | Antiglaucoma compositions and methods |
US4808610A (en) * | 1986-10-02 | 1989-02-28 | Schering Corporation | Mometasone furoate anti-inflammatory cream composition using hexylene glycol |
US4775529A (en) * | 1987-05-21 | 1988-10-04 | Schering Corporation | Steroid lotion |
PL165803B1 (pl) * | 1990-09-10 | 1995-02-28 | Schering Corp | Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL |
-
1991
- 1991-09-06 PL PL91298223A patent/PL165803B1/pl unknown
- 1991-09-06 AT AT91915453T patent/ATE113604T1/de active
- 1991-09-06 IL IL9943791A patent/IL99437A/en not_active IP Right Cessation
- 1991-09-06 ES ES91915453T patent/ES2065701T3/es not_active Expired - Lifetime
- 1991-09-06 HU HU9300685A patent/HU213401B/hu unknown
- 1991-09-06 CA CA002091360A patent/CA2091360C/en not_active Expired - Lifetime
- 1991-09-06 CZ CZ93383A patent/CZ281318B6/cs not_active IP Right Cessation
- 1991-09-06 DK DK91915453.4T patent/DK0548114T5/da active
- 1991-09-06 WO PCT/US1991/006249 patent/WO1992004365A1/en active IP Right Grant
- 1991-09-06 KR KR1019930700702A patent/KR960013445B1/ko not_active IP Right Cessation
- 1991-09-06 JP JP3514768A patent/JPH0725789B2/ja not_active Expired - Lifetime
- 1991-09-06 MX MX9203396A patent/MX9203396A/es unknown
- 1991-09-06 DE DE69104991T patent/DE69104991T2/de not_active Expired - Lifetime
- 1991-09-06 AU AU84974/91A patent/AU663471B2/en not_active Expired
- 1991-09-06 DE DE1991604991 patent/DE19875032I2/de active Active
- 1991-09-06 EP EP91915453A patent/EP0548114B1/en not_active Expired - Lifetime
- 1991-09-09 TW TW080107102A patent/TW229208B/zh not_active IP Right Cessation
- 1991-09-09 ZA ZA917148A patent/ZA917148B/xx unknown
- 1991-09-09 SI SI9111497A patent/SI9111497A/sl unknown
- 1991-09-09 YU YU149791A patent/YU48666B/sh unknown
- 1991-09-09 MX MX9100990A patent/MX9100990A/es unknown
- 1991-09-09 PH PH43072A patent/PH30443A/en unknown
- 1991-09-09 TW TW083106101A patent/TW272195B/zh not_active IP Right Cessation
- 1991-09-09 MY MYPI91001630A patent/MY106644A/en unknown
- 1991-09-09 IE IE315591A patent/IE67056B1/en not_active IP Right Cessation
- 1991-09-09 NZ NZ239711A patent/NZ239711A/en not_active IP Right Cessation
- 1991-09-09 PT PT98905A patent/PT98905B/pt not_active IP Right Cessation
- 1991-09-10 CN CN91108910A patent/CN1030920C/zh not_active Expired - Lifetime
-
1992
- 1992-09-21 HR HRP-1497/91A patent/HRP920383B1/xx not_active IP Right Cessation
-
1993
- 1993-02-26 NO NO930693A patent/NO300548B1/no not_active IP Right Cessation
- 1993-03-09 FI FI931031A patent/FI111078B/fi not_active IP Right Cessation
- 1993-03-09 OA OA60348A patent/OA09772A/en unknown
-
1994
- 1994-02-24 BG BG098564A patent/BG60755B2/bg unknown
- 1994-11-21 EE EE9400388A patent/EE02962B1/xx unknown
-
1995
- 1995-04-17 US US08/422,479 patent/US6180781B1/en not_active Expired - Lifetime
-
1996
- 1996-10-03 HK HK185996A patent/HK185996A/xx not_active IP Right Cessation
-
1998
- 1998-03-12 NL NL980012C patent/NL980012I2/nl unknown
-
1999
- 1999-03-05 LU LU90366C patent/LU90366I2/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI111078B (fi) | Menetelmä mometasonifuroaattimonohydraatin valmistamiseksi | |
US6127353A (en) | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions | |
EP3549932B1 (en) | Novel crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid and processes for preparation thereof | |
BG63338B1 (bg) | Кристални производни на n-ацетил невраминова киселина и методи за тяхното получаване | |
EP4092014A2 (en) | Crystalline form of fluvatinib or fluvatinib methanesulfonate and preparation method therefor | |
US4456753A (en) | Process for the manufacture of highly crystalline sodium cefoperazone | |
WO2012007453A1 (en) | Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol | |
US10717729B2 (en) | Thiamine-organic acid salt | |
BG61767B1 (bg) | Кристали от антимикробно съединение | |
EP0101170B1 (en) | Process for the manufacture of sodium cefoperazone | |
JP2663105B2 (ja) | 14α−ヒドロキシ−4−アンドロステン−3,6,17−トリオン水和物結晶及びその製造法 | |
US4419358A (en) | Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it | |
IE44319B1 (en) | A crystalline sodium salt of cephacetrile | |
EP3455229B1 (en) | Novel crystalline forms | |
CN107868117B (zh) | 司坦唑醇糖精盐及其制备方法和应用 | |
FI105034B (fi) | Kiteinen etoposidi-4'-fosfaattidietanolaatti | |
WO2021064166A1 (en) | Crystalline forms of bempedoic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Supplementary protection certificate application filed |
Spc suppl protection certif: L20030010 |
|
SPCG | Supplementary protection certificate granted |
Spc suppl protection certif: 219 Extension date: 20120219 |
|
MA | Patent expired |